Second Xiangya Hospital of Central South University
158
48
55
25
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
1.9%
3 terminated/withdrawn out of 158 trials
89.3%
+2.8% vs industry average
14%
22 trials in Phase 3/4
0%
0 of 25 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (158)
Neurobiological Mechanisms of Pathological Rumination and Effects of Aripiprazole
Role: collaborator
Intranasal Dexmedetomidine for Acute Anxiety State in Adults
Role: collaborator
Decreasing Risk of Psychosis by Sulforaphane (DROPS Trial)
Role: collaborator
Genetic Risk Score of Type 1 Diabetes Mellitus for Progression to Insulin in Diabetic Patients Lack of Predictive Value: a Multicenter Nested Case-control Study
Role: lead
Mobile Health and Wearable Devices for Diabetes Complication Management
Role: lead
rhBNP for Prevention of Cardiac Surgery-Associated Acute Kidney Injury (CSA-AKI)
Role: collaborator
Precise Profiling of Liver Disease Patients With DPMAS Therapy, Treating Optimal Patients and Achieving Hard Endpoint (PADSTONE Study)
Role: collaborator
A Phase II Study of NB001 for Acute Migraine Treatment
Role: collaborator
Effects of Cofrogliptin on Beta-Cell Function in LADA Patients
Role: lead
Evaluation of Chiglitazar Sodium With Lifestyle Intervention for Reversing Prediabetes
Role: lead
Effects of a Acceptance and Commitment Therapy-Based Psychosocial Intervention on Mental Health of Women With Perinatal Loss: A Pilot Randomised Controlled Trial
Role: lead
China Diabetes Type 1 Study (CD1S) by China Alliance for Type 1 Diabetes
Role: lead
A Clinical Study of Nanocrystalline Megestrol Acetate in Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer
Role: lead
Chronic Kidney Disease and Metabolic Disorders in the Elderly
Role: collaborator
ACT-based Parenting Program for Caregivers of Children With Hearing Loss Post-cochlear: A Pilot Randomised Controlled Trial
Role: lead
hiPSC-CMs-loaded Chitosan Patch to Treat Severe Chronic Ischemic Heart Disease
Role: collaborator
Tirofiban After Successful MT Recanalization in AIS
Role: collaborator
ctDNA-MRD Guided Escalation of Ivonescimab and Docetaxel in Advanced NSCLC With Long-Term Responses to First-line Immunotherapy (CR1STAL-Adaptive)
Role: lead
Efficacy and Safety of Different Doses of Rituximab Therapy in Pemphigus Patients
Role: collaborator
Laparoscopic Gastrectomy With D2 Lymphadenectomy Combined With Hyperthermic Intraperitoneal Chemotherapy (HIPEC) or Not
Role: collaborator